Cargando…
Kirsten Ras* oncogene: Significance of its discovery in human cancer research
The KRAS/ K-RAS oncogene is crucially involved in human cancer. The term “oncogene” – i.e., a gene able to transform a normal cell into a tumor cell – was introduced in 1969, but the word was not used in the human carcinogenesis literature until much later. Transforming Kras and Hras oncogenes from...
Autores principales: | Tsuchida, Nobuo, Murugan, Avaniyapuram Kannan, Grieco, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216832/ https://www.ncbi.nlm.nih.gov/pubmed/27102293 http://dx.doi.org/10.18632/oncotarget.8773 |
Ejemplares similares
-
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
por: Andreyev, H J N, et al.
Publicado: (2001) -
Identification and Characterization of Two Novel Oncogenic mTOR Mutations
por: Murugan, Avaniyapuram Kannan, et al.
Publicado: (2019) -
The regulatory G4 motif of the Kirsten ras (KRAS) gene is sensitive to guanine oxidation: implications on transcription
por: Cogoi, Susanna, et al.
Publicado: (2018) -
Role of Poly [ADP-ribose] Polymerase 1 in Activating the Kirsten
ras (KRAS) Gene in Response to Oxidative Stress
por: Cinque, Giorgio, et al.
Publicado: (2020) -
SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ disease
por: Murugan, Avaniyapuram Kannan, et al.
Publicado: (2021)